Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A drug that acts as a partial agonist selective for the dopamine receptor D2.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word aplindore.

Examples

  • This opens the possibility of dosing aplindore in RLS without prior titration.

    BioSpace.com Featured News and Stories 2008

  • -- (BUSINESS WIRE) -- Neurogen Corporation (Nasdaq: NRGN - News) today announced positive top-line results from two Phase 2 clinical trials in restless legs syndrome (RLS) and Parkinson's disease with the Company's dopamine partial agonist, aplindore.

    BioSpace.com Featured News and Stories 2008

  • In addition, aplindore was generally well tolerated and there were no withdrawals due to adverse events and no serious adverse events.

    BioSpace.com Featured News and Stories 2008

  • Patients titrated to higher aplindore doses (9 mg BID and 15 mg BID) over the same two-week period of time showed improvements that did not separate statistically from placebo.

    BioSpace.com Featured News and Stories 2008

  • In addition, aplindore was well tolerated with an incidence of adverse events similar to placebo in doses up to 0.2 mg.

    BioSpace.com Featured News and Stories 2008

  • These studies were the first in which aplindore has been evaluated in RLS and Parkinson's disease.

    BioSpace.com Featured News and Stories 2008

  • Patients titrated to higher aplindore doses (9 mg BID and 15 mg BID) over the same two-week period of time showed improvements that did not separate statistically from placebo.

    BioSpace.com Featured News and Stories 2008

  • Additionally, the study was designed to generate efficacy data with aplindore compared to placebo as measured by the mean change in the Unified Parkinson's Disease Rating Scale (UPDRS)

    BioSpace.com Featured News and Stories 2008

  • This finding suggests a possible decrease or plateauing of the observed effect in the upper dose range and that the future evaluation of aplindore should focus on the lower dose ranges.

    BioSpace.com Featured News and Stories 2008

  • Additionally, the study was designed to generate efficacy data with aplindore compared to placebo as measured by the mean change in the Unified Parkinson's Disease Rating Scale (UPDRS)

    BioSpace.com Featured News and Stories 2008

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.